$137 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 11 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | Phreesia, Inc. | $85,623,000 | -1.1% | 3,214,092 | -10.0% | 62.28% | +26.6% | |
FATE | Fate Therapeutics, Inc. | $22,306,000 | +26.0% | 1,139,783 | 0.0% | 16.22% | +61.3% | |
CDLX | Sell | Cardlytics, Inc. | $12,572,000 | -75.1% | 200,000 | -86.7% | 9.14% | -68.2% |
SELB | Selecta Biosciences, Inc. | $6,650,000 | +37.0% | 2,773,479 | 0.0% | 4.84% | +75.4% | |
XFOR | x4 Pharmaceuticals Inc. | $3,333,000 | -15.8% | 311,492 | 0.0% | 2.42% | +7.7% | |
STIM | Neuronetics, Inc. | $3,289,000 | -46.0% | 732,583 | 0.0% | 2.39% | -30.8% | |
KALA | Sell | Kala Pharmaceuticals, Inc. | $2,086,000 | -54.2% | 565,289 | -52.8% | 1.52% | -41.4% |
LIFE | Atyr Pharma Inc. | $544,000 | +19.0% | 130,571 | 0.0% | 0.40% | +52.3% | |
GNCA | Genocea Biosciences, Inc. | $509,000 | -28.7% | 246,078 | 0.0% | 0.37% | -8.9% | |
PULM | Pulmatrix, Inc. | $309,000 | +5.1% | 359,439 | 0.0% | 0.22% | +34.7% | |
DARE | Dare Bioscience, Inc. | $268,000 | +5.5% | 326,243 | 0.0% | 0.20% | +35.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
Trevena, Inc. | 22 | Q2 2019 | 24.9% |
Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
3 | 2022-03-30 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-12 |
13F-HR | 2021-05-12 |
13F-HR | 2021-02-12 |
13F-HR | 2020-11-12 |
13F-HR | 2020-08-12 |
13F-HR | 2020-05-14 |
4 | 2020-05-06 |
3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.